Log in

JOPD are very pleased to announce the appointment of Dr Yu Fang Yang as an Editorial Board Member. Yu is currently a postdoctoral fellow at the Freie Universität Berlin and has done some fantastic work surrounding face recognition, experimental methods, and open scholarship. Her impressive portfolio of contributions include work with the FORRT (Framework for Open and Reproducible Research Training) community, the ManyEEGPipelines project, the Chinese Open Science Network (COSN) and to new EEG ERP preregistration templates. You can find out more about her work here: https://yu-fang-yang.netlify.app/ and can connect via twitter (@ufangyang) and mastodon (@yufang_yang@fediscience.org). We are extremely pleased to have her expertise on the JOPD team!

We accept (self) nominations for Editorial Board members throughout the year so do get in touch if you have recommendations by emailing a name or CV to the Co-Editor, Thomas Rhys Evans (thomas.evans@greenwich.ac.uk). We look to represent our diverse community, including geographical region, career seniority, etc. so we particularly encourage those from communities who have been historically, or are currently, minoritized, discriminated against, or marginalised, to consider putting themselves forward.

We really value the contributions of our community, and as such we’ve now signed up to a brand-new initiative to recognise those who support us. We are happy to announce a new Reviewer Discount trial, where we offer a 30% APC discount to authors who have completed a review for us in the 12 months prior to submission. This brings our APC down from £450 to just £315! To secure this discount, you need to complete a review on time and to the quality expected by our Editors, and to acknowledge this (noting the article title and review date) in your cover letter when submitting to the journal. We hope this goes some way to express our thanks to all those individuals who invest their time to help the work published in our pages to be the highest quality it can be. If you have any questions about this trial please contact the Editors!